Written by Klarity Editorial Team
Published: May 20, 2026

Last updated: May 20, 2026
Ready to talk to a licensed provider about weight loss medication? See if you may qualify through Klarity →
Weight loss medication (also called anti-obesity medication or AOM) refers to FDA-approved drugs prescribed to help adults with obesity or weight-related health conditions lose weight alongside diet and exercise. These medications work through several mechanisms — some suppress appetite, others slow gastric emptying, and the newest class (GLP-1 receptor agonists) does both while also improving blood sugar regulation.
Weight loss medications are not appetite suppressants from a decade ago. The current generation of FDA-approved options — particularly GLP-1 receptor agonists — have clinical trial data showing 15–22% body weight reduction over 68–72 weeks, results that were previously only achievable through bariatric surgery.
GLP-1 (glucagon-like peptide-1) receptor agonists are now the most commonly prescribed weight loss medications through telehealth platforms. Here is what each approved option offers:
Semaglutide is a weekly injectable GLP-1 agonist. Wegovy (2.4 mg) is FDA-approved specifically for chronic weight management in adults with BMI ≥30, or BMI ≥27 with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol. Ozempic (0.5–2 mg) is FDA-approved for type 2 diabetes but is frequently prescribed off-label for weight management. Clinical trials showed an average weight loss of approximately 15% of body weight over 68 weeks with Wegovy.
Tirzepatide is a dual GIP and GLP-1 receptor agonist — the first of its class approved for weight loss. Zepbound received FDA approval for chronic weight management in 2023. Trials showed an average reduction of 20–22% of body weight at the highest dose (15 mg weekly), making it the highest-efficacy pharmacological option currently available. Mounjaro is its type 2 diabetes counterpart, also prescribed off-label for weight.
Providers may also prescribe orlistat (Xenical, Alli), phentermine/topiramate (Qsymia), naltrexone/bupropion (Contrave), or liraglutide (Saxenda) depending on your medical history, cost considerations, and how you tolerate injectable medications.
FDA labeling and most clinical guidelines require one of the following for GLP-1 prescriptions:
Your telehealth provider will review your full medical history, current medications, and any contraindications (such as a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, or pancreatitis history) before making a prescribing decision. Not every patient who requests a GLP-1 will receive one — your provider makes that determination based on clinical judgment.
Check if you may qualify for weight loss medication through Klarity →
Most telehealth weight loss visits last 20–30 minutes. Your provider will:
You do not need to be in a specific state to use telehealth for weight loss — providers practice in all 50 states, though individual provider availability varies.
The cost varies by medication, dose, insurance status, and pharmacy:
Insurance coverage for weight loss medications varies significantly by plan, employer, and state. Medicare Part D began covering GLP-1 medications for obesity in 2026 under certain conditions, though formularies differ by plan. Many commercial plans now cover Wegovy and Zepbound for patients meeting BMI criteria, but prior authorization is often required.
Disclaimer: Coverage for weight loss medications varies by insurance plan, employer benefits, and individual eligibility. Always verify your specific benefits directly with your insurer before booking a visit or filling a prescription. Your provider’s staff may be able to assist with prior authorization paperwork.
Klarity connects patients with 2,000+ licensed providers across the US who specialize in evidence-based care, including weight management. The platform supports video and asynchronous consultations, making it easy to attend a visit from home. Providers on Klarity can prescribe GLP-1 medications and other FDA-approved weight loss treatments where medically appropriate and state law permits.
See if you may qualify for weight loss medication with Klarity →
Yes. A licensed telehealth provider can prescribe semaglutide (Ozempic or Wegovy) for weight management if you meet clinical criteria. Wegovy is specifically FDA-approved for obesity; Ozempic is FDA-approved for type 2 diabetes and may be prescribed off-label for weight loss based on provider judgment.
Most patients complete the intake form and provider visit on the same day. E-prescriptions are typically sent to the pharmacy within 24–48 hours of a completed visit. Pharmacy dispensing time varies — mail-order pharmacies may take 3–7 business days for initial orders.
It is safe when you use a licensed telehealth platform where real, state-licensed providers conduct proper medical evaluations before prescribing. The clinical standards for GLP-1 prescribing through a reputable telehealth platform are the same as in-person care. Avoid platforms that prescribe without a provider consultation or that use unlicensed practitioners.
Not always, but it depends on your individual health history. Providers will often recommend baseline labs (HbA1c, fasting glucose, lipid panel, kidney function) if you have diabetes, prediabetes, or other relevant conditions. Your telehealth provider can order these labs at a local draw site near you.
Manufacturer savings programs, compounding pharmacy options (where clinically appropriate), and pharmacy discount cards (GoodRx, Cost Plus Drugs) may reduce out-of-pocket costs significantly. Your provider or care coordinator can discuss options during your visit. Coverage varies by plan — always verify your benefits directly.
Telehealth providers are licensed by state, so availability depends on whether a provider on the platform is licensed in your state. Major telehealth platforms, including Klarity, have provider coverage in all 50 states, though individual provider availability varies.
Getting weight loss medication online through a licensed telehealth provider is a medically sound, convenient option for adults who meet clinical criteria. GLP-1 medications like semaglutide and tirzepatide offer the strongest clinical evidence for significant, sustained weight loss. A telehealth visit takes 20–30 minutes, and if the provider determines medication is appropriate, an e-prescription goes to your preferred pharmacy the same day.
If you are considering weight loss medication, the first step is a conversation with a licensed provider who can evaluate your full picture and recommend the right treatment plan for you.
Check if you may qualify for weight loss medication through Klarity →
Find the right provider for your needs — select your state to find expert care near you.